SFX by Ex Libris Inc.

Title:	Homocysteine-induced cardiomyocyte apoptosis and plasma membrane flip-flop are independent of S-adenosylhomocysteine: a crucial role for nuclear p47phox
Source:	Molecular and Cellular Biochemistry [0300-8177] Sipkens, Jessica yr:2011

Basic

Full text

Full text available via SpringerLINK Contemporary 1997-Present

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Werstuck, G H H. "Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease." Cell death and differentiation 11.1 (2004): 56-64.
description	2.	Li, L. "Evaluation of the impacts of homocysteine and hypoxia on vascular endothelial function based on the profiling of neuro-endocrine-immunity network in rats." Pharmacological research 60.4 (2009): 277-283.
description	3.	Lentz, R. "Mechanisms of homocysteine-induced atherothrombosis." Journal of thrombosis and haemostasis 3.8 (2005): 1646-54.
description	4.	Clarke, R. "Homocysteine, renal function, and risk of cardiovascular disease." Kidney international. Supplement 84 (2003): -3.
description	5.	Weiss, N. "Mechanisms of increased vascular oxidant stress in hyperhomocys-teinemia and its impact on endothelial function." Current drug metabolism 6.1 (2005): 27-36.
description	6.	Kalhan, Satish C. "Methionine, homocysteine, one carbon metabolism and fetal growth." Reviews in endocrine and metabolic disorders 13.2 (2012): 1-11.
description	7.	van Guldener, C. "Homocysteine and asymmetric dimethylarginine (ADMA): biochemically linked but differently related to vascular disease in chronic kidney disease. (Special Issue: Homocysteine metabolism and hyperhomocysteinemia.)." Clinical chemistry and laboratory medicine 45.12 (2007): 1683-1687.
description	8.	Sanjdideh, Z. "Correlation of Hyperhomocysteinaemia and Chlamydia Pneumoniae IgG Seropositivity with Coronary Artery Disease in a General Population." Heart, lung & circulation 16.6 (2007): 416-22.
description	9.	Andersson, Sven E E. "Reduction of homocysteine in elderly with heart failure improved vascular function and blood pressure control but did not affect inflammatory activity." Basic & clinical pharmacology & toxicology (2005): 306-10.
description	10.	Selhub, J. "The many facets of hyperhomocysteinemia: studies from the Framingham cohorts." The Journal of nutrition 136.6 (2006): 1726-1730.
description	11.	DiBello, R. "Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease." Circulation 103.22 (2001): 2717-23.
description	12.	Kooner, J S S. "Improved vascular endothelial function after oral B vitamins: An effect mediated through reduced concentrations of free plasma homocysteine." Circulation 102.20 (2000): 2479-83.
description	13.	"Lowering homocysteine does not reduce CVD." The Journal of family practice 55.7 (2006): 570-570.
description	14.	Ayala, A. "Effects of short-term supplementation with folic acid on different oxidative stress parameters in patients with hypertension." Biochimica et biophysica acta 1726.2 (2005): 152-9.
description	15.	Hercberg, S. "[Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease?. 1. Basic data]." Pathologie biologie 51.2 (2003): 101-10.
description	16.	Moreno, P R R. "Metabolic syndrome and diabetic atherothrombosis: implications in vascular complications." Current molecular medicine 6.5: 501-14.
description	17.	Bleich, J. "Homocysteine as a neurotoxin in chronic alcoholism." Progress in neuro-psychopharmacology & biological psychiatry 28.3 (2004): 453-464.
description	18.	Williams, K M S M. "Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel." Journal of internal medicine 259.3 (2006): 247-258.
description	19.	McQueen, S. "Effect of homocysteine lowering B vitamins on carotid atherosclerosis: The homocysteine and atherosclerosis reduction trial (HART)." The Canadian journal of cardiology 23 (2007): 298-298.
description	20.	Lynne-C, J. "Osteonecrosis: etiology, diagnosis, and treatment." Current opinion in rheumatology 16.4 (2004): 443-449.